Exacerbations in cystic fibrosis: 2 . prevention.
The life span of people with cystic fibrosis (CF) has increased dramatically over the past 50 years. Many factors have contributed to this improvement. Respiratory exacerbations of CF lung disease are associated with the need for hospitalisation and antibiotic treatment, reduction in the quality of life, fragmented sleep and mortality. A number of preventive treatment strategies have been developed to reduce the frequency and severity of respiratory exacerbations in CF including mucolytic agents, physiotherapy and exercise, antibiotics, nutritional strategies, anti-inflammatory treatments and vaccinations against common respiratory pathogens. The evidence for each of these treatments and their potential impact is discussed.
Bell
Scott C
SC
Adult Cystic Fibrosis Centre, The Prince Charles Hospital, Rode Road, Chermside, Brisbane 4032, Australia. bell@health.qld.gov.au
Robinson
Philip J
PJ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D017281:Cost of Illness; D003550:Cystic Fibrosis / Q000150:complications* / Q000191:economics; D019587:Dietary Supplements; D005081:Exercise Therapy / Q000379:methods; D005100:Expectorants / Q000627:therapeutic use; D006801:Humans; D026741:Physical Therapy Modalities; D012120:Respiration Disorders / Q000517:prevention & control*; D014611:Vaccination
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D005100:Expectorants